Rep. Jackie Haas

Filed: 3/22/2024

 

 


 

 


 
10300HB4450ham001LRB103 36645 RLC 71279 a

1
AMENDMENT TO HOUSE BILL 4450

2    AMENDMENT NO. ______. Amend House Bill 4450 by replacing
3everything after the enacting clause with the following:
 
4    "Section 5. The Illinois Controlled Substances Act is
5amended by changing Section 208 and by by adding Section 309.1
6as follows:
 
7    (720 ILCS 570/208)  (from Ch. 56 1/2, par. 1208)
8    Sec. 208. (a) The controlled substances listed in this
9Section are included in Schedule III.
10    (b) Unless specifically excepted or unless listed in
11another schedule, any material, compound, mixture, or
12preparation which contains any quantity of the following
13substances having a stimulant effect on the central nervous
14system, including its salts, isomers (whether optical
15position, or geometric), and salts of such isomers whenever
16the existence of such salts, isomers, and salts of isomers is

 

 

10300HB4450ham001- 2 -LRB103 36645 RLC 71279 a

1possible within the specific chemical designation;
2        (1) Those compounds, mixtures, or preparations in
3    dosage unit form containing any stimulant substances
4    listed in Schedule II which compounds, mixtures, or
5    preparations were listed on August 25, 1971, as excepted
6    compounds under Title 21, Code of Federal Regulations,
7    Section 308.32, and any other drug of the quantitative
8    composition shown in that list for those drugs or which is
9    the same except that it contains a lesser quantity of
10    controlled substances;
11        (2) Benzphetamine;
12        (3) Chlorphentermine;
13        (4) Clortermine;
14        (5) Phendimetrazine.
15    (c) Unless specifically excepted or unless listed in
16another schedule, any material, compound, mixture, or
17preparation which contains any quantity of the following
18substances having a potential for abuse associated with a
19depressant effect on the central nervous system:
20        (1) Any compound, mixture, or preparation containing
21    amobarbital, secobarbital, pentobarbital or any salt
22    thereof and one or more other active medicinal ingredients
23    which are not listed in any schedule;
24        (2) Any suppository dosage form containing
25    amobarbital, secobarbital, pentobarbital or any salt of
26    any of these drugs and approved by the Federal Food and

 

 

10300HB4450ham001- 3 -LRB103 36645 RLC 71279 a

1    Drug Administration for marketing only as a suppository;
2        (3) Any substance which contains any quantity of a
3    derivative of barbituric acid, or any salt thereof:
4        (3.1) Aprobarbital;
5        (3.2) Butabarbital (secbutabarbital);
6        (3.3) Butalbital;
7        (3.4) Butobarbital (butethal);
8        (4) Chlorhexadol;
9        (5) Methyprylon;
10        (6) Sulfondiethylmethane;
11        (7) Sulfonethylmethane;
12        (8) Sulfonmethane;
13        (9) Lysergic acid;
14        (10) Lysergic acid amide;
15        (10.1) Tiletamine or zolazepam or both, or any salt of
16    either of them.
17    Some trade or other names for a tiletamine-zolazepam
18    combination product: Telazol.
19    Some trade or other names for Tiletamine:
20    2-(ethylamino)-2-(2-thienyl)-cyclohexanone.
21    Some trade or other names for zolazepam:
22    4-(2-fluorophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo-
23    [3,4-e], [1,4]-diazepin-7(1H)-one, and flupyrazapon.
24        (11) Any material, compound, mixture or preparation
25    containing not more than 12.5 milligrams of pentazocine or
26    any of its salts, per 325 milligrams of aspirin;

 

 

10300HB4450ham001- 4 -LRB103 36645 RLC 71279 a

1        (12) Any material, compound, mixture or preparation
2    containing not more than 12.5 milligrams of pentazocine or
3    any of its salts, per 325 milligrams of acetaminophen;
4        (13) Any material, compound, mixture or preparation
5    containing not more than 50 milligrams of pentazocine or
6    any of its salts plus naloxone HCl USP 0.5 milligrams, per
7    dosage unit;
8        (14) Ketamine;
9        (15) Thiopental; .
10        (16) Xylazine: (N-2,6-dimethylpheny1)-5,6-
11    dihydro-4H-1,3 thiazin-2-amine), including its isomers,
12    esters, ethers, salts, and salts of isomers, esters, and
13    ethers, whenever the existence of such isomers, esters,
14    ethers, and salts is possible within the specific chemical
15    designation.
16    (d) Nalorphine.
17    (d.5) Buprenorphine.
18    (e) Unless specifically excepted or unless listed in
19another schedule, any material, compound, mixture, or
20preparation containing limited quantities of any of the
21following narcotic drugs, or their salts calculated as the
22free anhydrous base or alkaloid, as set forth below:
23        (1) not more than 1.8 grams of codeine per 100
24    milliliters or not more than 90 milligrams per dosage
25    unit, with an equal or greater quantity of an isoquinoline
26    alkaloid of opium;

 

 

10300HB4450ham001- 5 -LRB103 36645 RLC 71279 a

1        (2) not more than 1.8 grams of codeine per 100
2    milliliters or not more than 90 milligrams per dosage
3    unit, with one or more active non-narcotic ingredients in
4    recognized therapeutic amounts;
5        (3) (blank);
6        (4) (blank);
7        (5) not more than 1.8 grams of dihydrocodeine per 100
8    milliliters or not more than 90 milligrams per dosage
9    unit, with one or more active, non-narcotic ingredients in
10    recognized therapeutic amounts;
11        (6) not more than 300 milligrams of ethylmorphine per
12    100 milliliters or not more than 15 milligrams per dosage
13    unit, with one or more active, non-narcotic ingredients in
14    recognized therapeutic amounts;
15        (7) not more than 500 milligrams of opium per 100
16    milliliters or per 100 grams, or not more than 25
17    milligrams per dosage unit, with one or more active,
18    non-narcotic ingredients in recognized therapeutic
19    amounts;
20        (8) not more than 50 milligrams of morphine per 100
21    milliliters or per 100 grams with one or more active,
22    non-narcotic ingredients in recognized therapeutic
23    amounts.
24    (f) Anabolic steroids, except the following anabolic
25steroids that are exempt:
26        (1) Androgyn L.A.;

 

 

10300HB4450ham001- 6 -LRB103 36645 RLC 71279 a

1        (2) Andro-Estro 90-4;
2        (3) depANDROGYN;
3        (4) DEPO-T.E.;
4        (5) depTESTROGEN;
5        (6) Duomone;
6        (7) DURATESTRIN;
7        (8) DUO-SPAN II;
8        (9) Estratest;
9        (10) Estratest H.S.;
10        (11) PAN ESTRA TEST;
11        (12) Premarin with Methyltestosterone;
12        (13) TEST-ESTRO Cypionates;
13        (14) Testosterone Cyp 50 Estradiol Cyp 2;
14        (15) Testosterone Cypionate-Estradiol Cypionate
15    injection; and
16        (16) Testosterone Enanthate-Estradiol Valerate
17    injection.
18    (g) Hallucinogenic substances.
19        (1) Dronabinol (synthetic) in sesame oil and
20    encapsulated in a soft gelatin capsule in a U.S. Food and
21    Drug Administration approved product. Some other names for
22    dronabinol: (6aR-trans)-6a,7,8,10a-tetrahydro-
23    6,6,9-trimethyl-3-pentyl-6H-dibenzo (b,d) pyran-1-ol) or
24    (-)-delta-9-(trans)-tetrahydrocannabinol.
25        (2) (Reserved).
26    (h) The Department may except by rule any compound,

 

 

10300HB4450ham001- 7 -LRB103 36645 RLC 71279 a

1mixture, or preparation containing any stimulant or depressant
2substance listed in subsection (b) from the application of all
3or any part of this Act if the compound, mixture, or
4preparation contains one or more active medicinal ingredients
5not having a stimulant or depressant effect on the central
6nervous system, and if the admixtures are included therein in
7combinations, quantity, proportion, or concentration that
8vitiate the potential for abuse of the substances which have a
9stimulant or depressant effect on the central nervous system.
10(Source: P.A. 100-368, eff. 1-1-18.)
 
11    (720 ILCS 570/309.1 new)
12    Sec. 309.1. Xylazine exemptions. Notwithstanding the
13scheduling of xylazine as a Schedule III controlled substance,
14xylazine shall not be considered a controlled substance when:
15    (1) used by licensed Illinois veterinarians dispensing or
16prescribing for, or administering to, a nonhuman species of a
17drug containing xylazine that has been approved by the U.S.
18Food and Drug Administration;
19    (2) used by licensed Illinois veterinarians dispensing or
20prescribing for, or administering to, a nonhuman species that
21is permissible under the Federal Food, Drug, and Cosmetic Act;
22    (3) manufactured, distributed, or used as an active
23pharmaceutical ingredient for manufacturing an animal drug
24approved under the Federal Food, Drug, and Cosmetic Act;
25    (4) used by a licensed certified euthanasia technician

 

 

10300HB4450ham001- 8 -LRB103 36645 RLC 71279 a

1employed by a certified euthanasia agency; or
2    (5) used by a wildlife biologist engaged in legal or
3authorized fieldwork under the indirect supervision of a
4veterinarian.".